Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Department of Surgery,
Division of Urology,
Department of Surgery, Division of Urology
Joshua Ejdelman has not added Biography.
If you are Joshua Ejdelman and would like to personalize this page please email our Author Liaison for assistance.
PTEN genomic deletion predicts prostate cancer recurrence and is associated with low AR expression and transcriptional activity.
BMC cancer , 2012 | Pubmed ID: 23171135
The 16p13.3 (PDPK1) Genomic Gain in Prostate Cancer: A Potential Role in Disease Progression.
Translational oncology Dec, 2012 | Pubmed ID: 23401739
McGill University
Palak G. Patel1,2,
Shamini Selvarajah1,2,
Suzanne Boursalie1,2,
Nathan E. How1,2,
Joshua Ejdelman3,
Karl-Philippe Guerard3,
John M. Bartlett4,
Jacques Lapointe3,
Paul C. Park1,
John B. A. Okello1,2,
David M. Berman1,2
1Department of Pathology & Molecular Medicine, Queen's University,
2Division of Cancer Biology & Genetics, Queen's Cancer Research Institute, Queen's University,
3Department of Surgery, Division of Urology, McGill University,
4Transformative Pathology Program, Ontario Institute for Cancer Research (OICR)
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved